Mackenzie Financial’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-97,443
Closed -$9.68M 1193
2019
Q3
$9.68M Buy
97,443
+7,997
+9% +$760K 0.03% 335
2019
Q2
$8.27M Sell
89,446
-11,023
-11% -$1.05M 0.02% 345
2019
Q1
$9.48M Sell
100,469
-741,767
-88% -$64.9M 0.02% 380
2018
Q4
$54M Sell
842,236
-253,732
-23% -$18.7M 0.14% 148
2018
Q3
$98.1M Buy
1,095,968
+9,113
+0.8% +$805K 0.24% 113
2018
Q2
$86.3M Buy
1,086,855
+464,276
+75% +$38.5M 0.22% 118
2018
Q1
$55.5M Buy
622,579
+497,937
+399% +$47.8M 0.14% 154
2017
Q4
$13M Buy
+124,642
New +$14.1M 0.03% 313
2016
Q4
Sell
-19,556
Closed -$2.04M 783
2016
Q3
$2.04M Sell
19,556
-285,330
-94% -$30.9M 0.01% 328
2016
Q2
$30.1M Sell
304,886
-41,679
-12% -$4.31M 0.17% 146
2016
Q1
$34.7M Sell
346,565
-2,165
-0.6% -$223K 0.31% 79
2015
Q4
$41.8M Buy
348,730
+8,785
+3% +$1.02M 0.26% 100
2015
Q3
$36.8M Sell
339,945
-28,256
-8% -$3.51M 0.22% 100
2015
Q2
$42.6M Buy
368,201
+74,730
+25% +$8.54M 0.23% 102
2015
Q1
$33.8M Buy
293,471
+145,770
+99% +$17.4M 0.18% 134
2014
Q4
$16.5M Buy
147,701
+80,410
+119% +$8.48M 0.08% 194
2014
Q3
$6.38M Sell
67,291
-40,589
-38% -$3.66M 0.03% 296
2014
Q2
$9.27M Sell
107,880
-20,228
-16% -$1.54M 0.04% 266
2014
Q1
$8.94M Buy
128,108
+16,500
+15% +$1.31M 0.04% 264
2013
Q4
$9.43M Buy
111,608
+46,100
+70% +$3.65M 0.05% 244
2013
Q3
$5.05M Buy
65,508
+47,168
+257% +$3.31M 0.03% 301
2013
Q2
$1.07M Buy
+18,340
New +$1.1M 0.01% 480

Other funds holding CELG

Mackenzie Financial's CELG Position: Q4 2019 in Review

Mackenzie Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 97,443 shares — an estimated $9.68M sold.

Mackenzie Financial first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $98.1M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Mackenzie Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Mackenzie Financial sold 97,443 Celgene Corp shares in Q4 2019, an estimated $9.68M.
  • Mackenzie Financial first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
  • Mackenzie Financial's Celgene Corp position peaked at $98.1M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Mackenzie Financial's 13F filing for Q4 2019, filed 13 Feb 2020.